Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted drug products, with a primary focus in oncology. Spectrum has a strong track record for in-licensing and acquiring differentiated drugs, and for clinical development. Spectrum has a late-stage pipeline that has the potential to transform the company.
Our passion to identify, develop and deliver important options for patients suffering from cancer is behind every action we take. At Spectrum, we are committed to excellence and strive to make a difference in the lives of patients every day.
Spectrum Pharmaceuticals actively seeks and evaluates potentially important drug candidates. Once we identify these candidates, we rapidly assess preclinical and clinical data, and the commercialization potential of candidates. Then through both in-licensing and co-development partnerships, we provide the expertise and necessary funding to bring the most promising products through the complex development process to market.
|You may contact Spectrum's Compliance Officer at any time at: firstname.lastname@example.org|
|Notice of Compliance|
|Code of Business Conduct and Ethics|
|Code of Business Conduct and Ethics in Spanish (en español).|
Visit our careers page to learn about new job opportunities and how to become a part of the Spectrum team.
Collectively, the members of our team have relevant experience in both the development and marketing of oncology drugs and the growth of profitable business ventures.